Pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia

Abstract

Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear receptors that regulate lipid metabolism and bioenergetic demands within living systems. Consequently, aberrant expression of PPAR genes could predispose individuals to diseases including cancer. PPAR signaling exerts pleiotropic functions in cancer, yet, little is known about the interactions between genetic and transcriptional events of pathway genes in a pan-cancer context. Employing multidimensional datasets of over 18,000 patients involving 21 cancers, we performed systematic characterization on copy number alteration and differential transcript expression of 74 PPAR pathway genes. We identified 18 putative driver candidates demonstrating mutually exclusive patterns of loss-and gain-of-function phenotypes. These driver genes successfully predicted patient survival rates in bladder, renal, glioma, liver and stomach/esophageal cancers. Dysregulated PPAR signaling in these cancers converged on common downstream pathways associated with multiple metabolic processes. Moreover, clinically-relevant relationships between PPARs and hypoxia were observed where hypoxia further aggravates disease phenotypes in tumor subtypes with aberrant PPAR signaling. In glioma samples, including astrocytoma and oligoastrocytoma, PPAR hyperactivation is associated with immunosuppression through increased regulatory T cell expression. Our analysis reveals underappreciated levels of diversity and conservation in PPAR genes that could lay the groundwork for therapeutic strategies targeting tumor metabolism, immunity and hypoxia. PPAR | genomic alterations | metabolism | hypoxia | tumor immunity | glioma | hepatocellular carcinoma | renal cancer | pan-cancerCorrespondence: alvina.lai@ndm.ox.ac.uk

Aberrations in Notch-Hedgehog signalling reveal cancer stem cells harbouring conserved oncogenic properties associated with hypoxia and immunoevasion

“…Cancer abbreviations were listed in Table S2 signalling were characterised by molecular footprints of stemness and that there was significant crosstalk between Notch-Hedgehog and other pathways involved in controlling tumour initiation. 28,29 Additionally, Gene Ontology analyses revealed significant enrichments of processes related to cell differentiation, cell proliferation, embryo development and morphogenesis ( Fig. 3d), supporting the hypothesis that tumour aggression and elevated mortality could be caused by the presence of CSCs that are likely to be refractory to therapy.…”

The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis

“…PPARs are involved in the regulation of metabolic homeostasis, whose activity are controlled by fatty acid ligands 34 . After activation, PPARs heterodimerize with retinoid X receptors (RXRs) to affect the expression of www.nature.com/scientificreports www.nature.com/scientificreports/ downstream genes.…”

Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer

“…The GO analysis unveiled that these DE-mRNAs were greatly enriched in some cancer-related GO items such as cell adhesion [39], cell-matrix adhesion [40], regulation of cell cycle and angiogenesis [41]. In addition, KEGG pathway enrichment analysis also proved that these significant DE-mRNAs had association with mTOR signaling pathway and p53 signaling pathway, which regulated the invasion and metastasis of cervical cancer [42,43]. These results suggested that DE-mRNAs identified through intersection of GEO datasets may play important roles in cervical cancer.…”